weight management program with tirzepatide Explained: The Future of Tirzepatide (Mounjaro®) Weight Management Program
Description
Last updated April 2026 Sources verified against the Zepbound FDA prescribing information, NEJM SURMOUNT-1 (Jastreboff et al., 2022), and Lillys Zepbound consumer page
This ensures that the medication and dosage are appropriate for your specific health profile and weight loss goals
Tirzepatide targets GIP and GLP-1
A full plan diet, exercise, follow-up labs, and behavioural counselling
Expect increased side effects, particularly nausea and reduced appetite, over the following 3-5 days
